UPM Institutional Repository

The use of aripiprazole in early onset schizophrenia: safety and efficacy


Ibrahim, Normala and Awang, Hamidin (2009) The use of aripiprazole in early onset schizophrenia: safety and efficacy. Medical Journal of Malaysia, 64 (3). pp. 240-241. ISSN 0300-5283


The use of atypical antipsychotic agents in early onset schizophrenia is rising despite its limited data on efficacy, safety and tolerability. Early onset schizophrenia warrants effective pharmacological treatment that is safe and well tolerated by children and adolescent population. Existing atypical agents are not completely free of side effects. Aripiprazole has unique properties that differ from other atypical antipsychotics and fill up the missing gaps, as it is associated with minimal metabolic complications and extrapyramidal side effects that are more commonly seen in other atypical agents. It offers a better option for this population and may possibly be considered as first line treatment in future. This case report demonstrates the efficacy and safety of Aripiprazole in children and adolescent population.

Download File

PDF (Abstract)
The use of aripiprazole in early onset schizophrenia.pdf

Download (84kB) | Preview

Additional Metadata

Item Type: Article
Subject: Schizophrenia.
Subject: Schizophrenia - Therapy.
Divisions: Faculty of Medicine and Health Science
Publisher: Malaysian Medical Association
Keywords: Aripiprazole; Atypical antipsychotics; Early onset schizophrenia.
Depositing User: Raja Norazlinda Raja Azenam
Date Deposited: 19 Feb 2013 04:18
Last Modified: 29 Sep 2015 02:51
URI: http://psasir.upm.edu.my/id/eprint/17356
Statistic Details: View Download Statistic

Actions (login required)

View Item View Item